OPTIBIOTIX HEALTH PLC Logo

OPTIBIOTIX HEALTH PLC

Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.

OPTI | IL

Overview

Corporate Details

ISIN(s):
GB00BP0RTP38
LEI:
213800UKYQFT941QHS14
Country:
United Kingdom
Address:
Innovation Centre Innovation Way, YO10 5DG York
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

OptiBiotix Health PLC is a life sciences company specializing in the research and development of technologies that modulate the human microbiome. The company identifies and develops microbial strains, compounds, and formulations for use as food ingredients and supplements. Its core focus is on the prevention and management of chronic lifestyle diseases, including obesity, hypercholesterolemia (high cholesterol), and diabetes. The company's approach is underpinned by scientific research and human clinical studies, delivering proprietary ingredients like SlimBiome® and LPLDL® as well as white-label product solutions to its commercial partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-02 08:00
Director's Dealing
Director/PDMR Shareholding
English 33.8 KB
2025-09-24 13:28
Director's Dealing
Director/PDMR Shareholding
English 43.8 KB
2025-09-16 08:00
Interim Report
Half-year Report
English 230.4 KB
2025-08-21 08:00
Delisting Announcement
Admission to Trading on the OTCQB Venture Market
English 14.4 KB
2025-08-20 08:00
Regulatory News Service
Agreement with Weight Management Company
English 15.1 KB
2025-08-14 08:00
Regulatory News Service
Launch of SlimBiome in leading US brand
English 17.0 KB
2025-08-06 17:08
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
English 13.9 KB
2025-08-06 08:00
Share Issue/Capital Change
Issue of Options
English 31.2 KB
2025-07-28 08:00
Earnings Release
Trading update
English 19.1 KB
2025-06-30 08:00
Earnings Release
Final Results
English 544.3 KB
2025-06-30 08:00
Regulatory News Service
Change of Broker
English 11.6 KB
2025-06-11 08:00
Environmental & Social Information
SlimBiome® study in European Journal of Nutrition
English 28.0 KB
2025-05-23 08:00
Share Issue/Capital Change
Placing and Issue of Warrants
English 20.6 KB
2025-03-18 08:00
Business and Financial Review
Commercial Update
English 35.7 KB
2025-02-18 08:00
Regulatory News Service
Launch of Daily Nouri FeelFull product in America
English 18.4 KB

Automate Your Workflow. Get a real-time feed of all OPTIBIOTIX HEALTH PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for OPTIBIOTIX HEALTH PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Read Gene Spolka Akcyjna Logo
Develops DNA tests to identify genetic cancer risk for early detection and prevention.
Poland RDG
RELIEF Therapeutics Holding AG Logo
Developing and commercializing novel therapies for rare and ultra-rare diseases.
Switzerland RLF
RYVU Therapeutics S.A. Logo
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland RVU
SAREUM HOLDINGS PLC Logo
Clinical-stage developer of kinase inhibitors for autoimmune disease & cancer.
United Kingdom SAR
SCANCELL HOLDINGS PLC Logo
Developing therapeutic vaccines and antibodies for cancer and infectious diseases.
United Kingdom SCLP
SCIENCE GROUP PLC Logo
International science & tech consultancy providing advisory, R&D, and product development.
United Kingdom SAG
Selvita S.A. Logo
Preclinical CRO offering integrated drug discovery and development services for life sciences.
Poland SLV
Simris Group AB Logo
Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.
Sweden SIMRIS
SKINBIOTHERAPEUTICS PLC Logo
A life science company developing microbiome-based skin health products and supplements.
United Kingdom SBTX
Terranet B Logo
Develops ultra-fast ADAS anti-collision technology for automakers to protect vulnerable road users.
Sweden TERRNT

Talk to a Data Expert

Have a question? We'll get back to you promptly.